(Q41774096)

9 October 2017

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results (English)

1 reference

9 October 2017

1 reference

retinal vein occlusion

1 reference

Raba Thapa

1

1 reference

9 October 2017

Nhukesh Maharjan

series ordinal

2

1 reference

9 October 2017

Govinda Paudyal

series ordinal

3

1 reference

9 October 2017

language of work or name

English

0 references

publication date

12 July 2012

1 reference

9 October 2017

Clinical Ophthalmology

1 reference

9 October 2017

6

1 reference

9 October 2017

1057-1062

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

9 October 2017

start time

1 July 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Demographic characteristics, patterns and risk factors for retinal vein occlusion in Nepal: a hospital-based case-control study

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Treatment of branch retinal vein occlusion induced macular edema with bevacizumab

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Results of bevacizumab as the primary treatment for retinal vein occlusions

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Prevalence and risk factors of retinal vein occlusion in an Asian population.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413343

Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22888203

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/OPTH.S30555

1 reference

9 October 2017

1 reference

9 October 2017

PubMed publication ID

22888203

1 reference